gossypol has been researched along with prednisolone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chayun, OA; Chernyavski, AI; Drannik, GN; Glukhenky, BT; Grando, SA; Kostromin, AP; Romanenko, AB | 1 |
| Guang, ZZ; Jiang, WQ; Li, ZM; Liu, ZC; Yang, DJ; Zhou, JM; Zhu, XF; Zhu, ZY | 1 |
| Garrido Castro, P; Pieters, R; Pinhanços, SM; Schneider, P; Spijkers-Hagelstein, JA; Stam, RW | 1 |
4 other study(ies) available for gossypol and prednisolone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Clinical and laboratory evaluation of hemocarboadsorption in autoimmune bullous dermatoses.
Topics: Adsorption; Adult; Aged; Animals; Autoantibodies; Autoimmune Diseases; Carbon; Female; Gossypol; Hemofiltration; Humans; Immunosuppressive Agents; Male; Mice; Middle Aged; Pemphigoid, Bullous; Pemphigus; Prednisolone; Skin Diseases, Vesiculobullous | 1990 |
Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclins; Cyclophosphamide; Doxorubicin; Drug Synergism; Etoposide; Gossypol; Humans; Lymphoma, Non-Hodgkin; Paclitaxel; Prednisolone; Tumor Suppressor Protein p53; Vincristine | 2008 |
Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Order; Glucocorticoids; Gossypol; Humans; Infant; Leukemia, Biphenotypic, Acute; Myeloid Cell Leukemia Sequence 1 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Proto-Oncogene Proteins c-bcl-2; Sirolimus; Tumor Cells, Cultured | 2014 |